NFE2L2 and acute lymphoblastic leukemia: In our study, AZD0364 and ZSTK474 alone and in combination markedly decreased NF-κB and NRF2 protein levels, which was accompanied by a significant decrease in HO-1 and TrxR protein levels in B-ALL REH cells.